These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 19856877

  • 1. [PET-CT in evaluation of pulmonary nodule--case report].
    Zielonka TM, Pietrzykowski J, Wardyn KA.
    Pol Merkur Lekarski; 2009 Aug; 27(158):119-22. PubMed ID: 19856877
    [Abstract] [Full Text] [Related]

  • 2. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules.
    Bryant AS, Cerfolio RJ.
    Ann Thorac Surg; 2006 Sep; 82(3):1016-20. PubMed ID: 16928527
    [Abstract] [Full Text] [Related]

  • 3. 18-fluorine fluorodeoxyglucose positron emission tomography with computerized tomography versus computerized tomography alone for the management of solitary lung nodules with diameters inferior to 1.5 cm.
    Divisi D, Di Tommaso S, Di Leonardo G, Brianzoni E, De Vico A, Crisci R.
    Thorac Cardiovasc Surg; 2010 Oct; 58(7):422-6. PubMed ID: 20922626
    [Abstract] [Full Text] [Related]

  • 4. Imaging of lung hamartomas by multidetector computed tomography and positron emission tomography.
    De Cicco C, Bellomi M, Bartolomei M, Carbone G, Pelosi G, Veronesi G, De Pas T, Spaggiari L, Paganelli G.
    Ann Thorac Surg; 2008 Dec; 86(6):1769-72. PubMed ID: 19021972
    [Abstract] [Full Text] [Related]

  • 5. Diagnostic performance of PET/CT in differentiation of malignant and benign non-solid solitary pulmonary nodules.
    Tsushima Y, Tateishi U, Uno H, Takeuchi M, Terauchi T, Goya T, Kim EE.
    Ann Nucl Med; 2008 Aug; 22(7):571-7. PubMed ID: 18756359
    [Abstract] [Full Text] [Related]

  • 6. Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT.
    Christensen JA, Nathan MA, Mullan BP, Hartman TE, Swensen SJ, Lowe VJ.
    AJR Am J Roentgenol; 2006 Nov; 187(5):1361-7. PubMed ID: 17056930
    [Abstract] [Full Text] [Related]

  • 7. Differentiation of lung neoplasms with lepidic growth and good prognosis from those with poor prognosis using computer-aided 3D volumetric CT analysis and FDG-PET.
    Morimoto D, Takashima S, Sakashita N, Sato Y, Jiang B, Hakucho T, Miyake C, Takahashi Y, Tomita Y, Nakanishi K, Hosoki T, Higashiyama M.
    Acta Radiol; 2014 Jun; 55(5):563-9. PubMed ID: 24003260
    [Abstract] [Full Text] [Related]

  • 8. Growth of a solitary pulmonary nodule after 6years diagnosed as oncocytic carcinoid tumour with a high 18-fluorodeoxyglucose (18F-FDG) uptake in positron emission tomography-computed tomography (PET-CT).
    Turan O, Ozdogan O, Gurel D, Onen A, Kargi A, Sevinc C.
    Clin Respir J; 2013 Jan; 7(1):e1-5. PubMed ID: 22129499
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Difficulties encountered managing nodules detected during a computed tomography lung cancer screening program.
    Veronesi G, Bellomi M, Scanagatta P, Preda L, Rampinelli C, Guarize J, Pelosi G, Maisonneuve P, Leo F, Solli P, Masullo M, Spaggiari L.
    J Thorac Cardiovasc Surg; 2008 Sep; 136(3):611-7. PubMed ID: 18805261
    [Abstract] [Full Text] [Related]

  • 12. PET for the evaluation of solitary pulmonary nodules.
    Fisher RE.
    J Nucl Med; 2009 Feb; 50(2):326; author reply 326-7. PubMed ID: 19164230
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules.
    Daniels CE, Lowe VJ, Aubry MC, Allen MS, Jett JR.
    Chest; 2007 Jan; 131(1):255-60. PubMed ID: 17218584
    [Abstract] [Full Text] [Related]

  • 15. Unexpected slight fluorodeoxyglucose-uptake on positron emission tomography in a pulmonary hamartoma.
    Himpe U, Deroose CM, Leyn PD, Verbeken E, Vansteenkiste J.
    J Thorac Oncol; 2009 Jan; 4(1):107-8. PubMed ID: 19096317
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Differentiation between malignancy and inflammation in pulmonary ground-glass nodules: The feasibility of integrated (18)F-FDG PET/CT.
    Chun EJ, Lee HJ, Kang WJ, Kim KG, Goo JM, Park CM, Lee CH.
    Lung Cancer; 2009 Aug; 65(2):180-6. PubMed ID: 19155090
    [Abstract] [Full Text] [Related]

  • 18. The sensitivity of 18F-fluorodeoxyglucose positron emission tomography in the evaluation of metastatic pulmonary nodules.
    Fortes DL, Allen MS, Lowe VJ, Shen KR, Wigle DA, Cassivi SD, Nichols FC, Deschamps C.
    Eur J Cardiothorac Surg; 2008 Dec; 34(6):1223-7. PubMed ID: 18848459
    [Abstract] [Full Text] [Related]

  • 19. A comparison of the diagnostic accuracy of 18F-FDG PET and CT in the characterization of solitary pulmonary nodules.
    Fletcher JW, Kymes SM, Gould M, Alazraki N, Coleman RE, Lowe VJ, Marn C, Segall G, Thet LA, Lee K, VA SNAP Cooperative Studies Group.
    J Nucl Med; 2008 Feb; 49(2):179-85. PubMed ID: 18199626
    [Abstract] [Full Text] [Related]

  • 20. Dynamic MRI, dynamic multidetector-row computed tomography (MDCT), and coregistered 2-[fluorine-18]-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET)/CT: comparative study of capability for management of pulmonary nodules.
    Ohno Y, Koyama H, Takenaka D, Nogami M, Maniwa Y, Nishimura Y, Ohbayashi C, Sugimura K.
    J Magn Reson Imaging; 2008 Jun; 27(6):1284-95. PubMed ID: 18504748
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.